MedPath

Evaluation of Indices of Body Composition During Ultramarathon : Measure by Body Bioelectrical Impedance

Not Applicable
Completed
Conditions
Healthy Volunteers
Interventions
Device: body bioelectrical impedance performed by Z-Métrix (class IIa) - BIOPARHOM 12 allée des lacs de garde, Savoie Technolac BP 238, 73374 Bourget du lac, France
Registration Number
NCT01906203
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Prospective cohort, monocentric non-randomized and interventional clinical study in ICU assessing the evolution of body composition using bioelectrical impedance analysis.

Detailed Description

Prospective, monocentric non-randomized and interventional clinical study in ICU assessing the evolution of body composition using bioelectrical impedance analysis (phase angle, fat mass, muscle mass, fat-free mass, body water) before and after ultramarathon.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Participation to ultramarathon
Exclusion Criteria
  • pregnancy women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ultramarathonbody bioelectrical impedance performed by Z-Métrix (class IIa) - BIOPARHOM 12 allée des lacs de garde, Savoie Technolac BP 238, 73374 Bourget du lac, France-
Primary Outcome Measures
NameTimeMethod
Difference of fat-free mass, using bioelectrical impedance analysisbefore and after ultramarathon of 105 km (at day 1)
Secondary Outcome Measures
NameTimeMethod
Correlation between order in the course,duration of course and indices of body compositionat day 1 (during ultramarathon of 105 km)
Difference of phase angle, using bioelectrical impedance analysisat day 1(before and after ultramarathon)

Trial Locations

Locations (1)

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath